Stock Events

Stock Events

Corvus Pharmaceuticals (C17.F) Q2 2026 Earnings

May 7Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.13

-0.11

-0.1

-0.09

Details

Expected EPS

-0.12144493543000001

Actual EPS

-0.1279005

Surprise EPS

-0.01

Surprise Percent

-5.32%

Description

⁨Corvus Pharmaceuticals⁩ (⁦C17.F⁩) has reported earnings of ⁦-0.1279005⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.